ROSSARI BIOTECH LIMITED
ROSSARI · General/Diversified · NSE
₹513
Current Market Price
Fair Value (DCF)
₹454
Margin of Safety
-11.5%
Updated 1d ago
YieldIQ Score
51/100
Piotroski F-Score
5/9
Economic Moat
Narrow
Confidence
38%
ROE
—
Debt/Equity
0.28
WACC
11.1%
Market Cap
₹2,841 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
14.9%
Return on capital employed
EV / EBITDA
12.1×
Enterprise multiple
Debt / EBITDA
0.8×
Leverage vs earnings
Interest Coverage
11.4×
EBIT covers interest
Current Ratio
1.94×
Short-term liquidity
Asset Turnover
1.09×
Revenue per ₹ of assets
Revenue CAGR (3Y)
12.0%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹513
Bear case
₹269.41
MoS -90.4%
Base case
₹454.19
MoS -12.9%
Bull case
₹579.97
MoS +11.5%
Ratio Trends
ROSSARI · last 5 annual periods
ROE
11.5%
ROCE
19.2%
Operating Margin
—
Debt / Equity
0.18×
PE
113.9×
EV / EBITDA
14.3×
Historical Financials
ROSSARI · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹709 Cr | ₹1483 Cr | ₹406 Cr | ₹473 Cr | ₹2071 Cr | +30.7% |
| EBITDA | — | ₹197 Cr | ₹229 Cr | ₹257 Cr | ₹270 Cr | +8.2% |
| EBIT | ₹109 Cr | ₹147 Cr | ₹41.4 Cr | ₹47.9 Cr | — | -18.7% |
| PAT | ₹80.0 Cr | ₹97.7 Cr | ₹29.0 Cr | ₹34.1 Cr | ₹136 Cr | +14.2% |
| EPS (diluted) | ₹15.47 | ₹17.70 | ₹5.24 | ₹6.17 | — | -20.5% |
| CFO | ₹47.8 Cr | ₹29.4 Cr | ₹152 Cr | ₹43.3 Cr | ₹137 Cr | +30.2% |
| CapEx | — | — | — | — | ₹-159 Cr | — |
| FCF | — | — | — | — | ₹-21.1 Cr | — |
| Total Assets | — | ₹1257 Cr | ₹1368 Cr | ₹1572 Cr | ₹1896 Cr | +10.8% |
| Total Debt | — | — | ₹39.0 Cr | ₹72.5 Cr | ₹218 Cr | +53.8% |
| Shareholders' Equity | — | — | ₹915 Cr | ₹1048 Cr | ₹1185 Cr | +6.7% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ROSSARI vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| POLYPLEX POLYPLEX | — | — | Pending | 3.4% | — |
| JUBLCPL JUBILANT AGRI N CON PRO L | -14.0% | 57 | Fairly valued | 27.0% | — |
| KIRIINDUS KIRIINDUS | — | — | Pending | 8.2% | — |
| NOCIL NOCIL | — | — | Pending | 5.8% | — |
| FCL FCL | — | — | Pending | 14.6% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for ROSSARI in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ROSSARI →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ROSSARI →
Compare
Head-to-head with peers
Compare ROSSARI side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ROSSARINow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.